
Release date: 2026-02-06 17:32:34 Article From: Lucius Laos Recommended: 130
Belzutifan produced by Lucius Pharmaceuticals is a bioequivalent generic drug with the same mechanism of action as the marketed drug. It is indicated for the treatment of diseases such as renal cell carcinoma and is generally more affordably priced.
Be sure to inform your doctor of any prescription or over-the-counter medicines, vitamins/minerals, herbal products and other supplements you are taking.
In particular, make sure to discuss whether you are using hormone-containing birth control pills, patches, vaginal rings, implants, injections or intrauterine devices.
Certain other medications may alter the blood concentration of Belzutifan, and vice versa. Please inform your doctor of all medications you are taking or have recently taken.
This may not be a complete list of medications that may interact with Lucius Pharmaceuticals' version of Belzutifan. Be sure to consult your doctor.
Currently, there are no known interactions between Lucius Pharmaceuticals' version of Belzutifan and food or beverages.
It is unknown whether alcohol consumption affects Belzutifan.
If you or someone else has taken an overdose of Belzutifan, seek medical help immediately and contact your doctor or pharmacist.
If you miss a dose, take it as soon as you remember on the same day. Then take your next dose at your usual time the following day. Do not take a double or extra dose.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long reli···【more】
Recommended:[list:visits]2026-26-06
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegroma···【more】
Recommended:[list:visits]2026-24-06
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended:[list:visits]2026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:[list:visits]2025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:[list:visits]2025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:[list:visits]2025-08-12

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643